Suppr超能文献

超重/肥胖且伴有或不伴有冠心病人群中 HDL 亚群蛋白组与 HDL 功能之间的关系。

Relationships between HDL subpopulation proteome and HDL function in overweight/obese people with and without coronary heart disease.

机构信息

UW Medicine Diabetes Institute, Department of Medicine, University of Washington, Seattle, WA, USA.

UW Medicine Diabetes Institute, Department of Medicine, University of Washington, Seattle, WA, USA.

出版信息

Atherosclerosis. 2024 Oct;397:118565. doi: 10.1016/j.atherosclerosis.2024.118565. Epub 2024 Aug 13.

Abstract

BACKGROUND AND AIMS

The structure-function relationships of high-density lipoprotein (HDL) subpopulations are not well understood. Our aim was to examine the interrelationships between HDL particle proteome and HDL functionality in subjects with and without coronary heart disease (CHD).

METHODS

We isolated 5 different HDL subpopulations based on charge, size, and apolipoprotein A1 (APOA1) content from the plasma of 33 overweight/obese CHD patients and 33 age-and body mass index (BMI)-matched CHD-free subjects. We measured the relative molar concentration of HDL-associated proteins by liquid chromatography tandem mass spectrometry (LC-MS/MS) and assessed particle functionality.

RESULTS

We quantified 110 proteins associated with the 5 APOA1-containing HDL subpopulations. The relative molar concentration of these proteins spanned five orders of magnitude. Only 10 proteins were present in >1% while 73 were present in <0.1% concentration. Only 6 of the 10 most abundant proteins were apolipoproteins. Interestingly, the largest (α-1) and the smallest (preβ-1) HDL particles contained the most diverse proteomes. The protein composition of each HDL subpopulation was altered in CHD cases as compared to controls with the most prominent differences in preβ-1 and α-1 particles. APOA2 concentration was positively correlated with preβ-1 particle functionality (ABCA1-CEC/mg APOA1 in preβ-1) (R = 0.42, p = 0.005), while APOE concentration was inversely correlated with large-HDL particle functionality (SRBI-CEC/mg APOA1 in α-1+α-2) (R = 0.18, p = 0.01).

CONCLUSIONS

The protein composition of the different HDL subpopulations was altered differentially in CHD patients. The functionality of the small and large HDL particles correlated with the protein content of APOA2 and APOE, respectively. Our data indicate that distinct particle subspecies and specific particle associated proteins provide new information about the role of HDL in CHD.

摘要

背景与目的

高密度脂蛋白(HDL)亚群的结构-功能关系尚不清楚。本研究旨在探讨冠心病(CHD)患者和非冠心病(CHD)患者的 HDL 颗粒蛋白质组与 HDL 功能之间的相互关系。

方法

我们从 33 名超重/肥胖的 CHD 患者和 33 名年龄和体重指数(BMI)匹配的非 CHD 患者的血浆中分离了 5 种不同的基于电荷、大小和载脂蛋白 A1(APOA1)含量的 HDL 亚群。我们通过液相色谱串联质谱(LC-MS/MS)测量了与 HDL 相关的蛋白质的相对摩尔浓度,并评估了颗粒功能。

结果

我们定量了与 5 种 APOA1 含量的 HDL 亚群相关的 110 种蛋白质。这些蛋白质的相对摩尔浓度跨越了五个数量级。只有 10 种蛋白质的浓度超过 1%,而 73 种蛋白质的浓度低于 0.1%。在 10 种最丰富的蛋白质中,只有 6 种是载脂蛋白。有趣的是,最大的(α-1)和最小的(preβ-1)HDL 颗粒含有最多样化的蛋白质组。与对照组相比,CHD 病例中每种 HDL 亚群的蛋白质组成都发生了改变,preβ-1 和α-1 颗粒的变化最为明显。APOA2 浓度与 preβ-1 颗粒功能呈正相关(preβ-1 中 ABCA1-CEC/mg APOA1)(R=0.42,p=0.005),而 APOE 浓度与大 HDL 颗粒功能呈负相关(α-1+α-2 中 SRBI-CEC/mg APOA1)(R=0.18,p=0.01)。

结论

CHD 患者不同 HDL 亚群的蛋白质组成发生了不同的改变。小和大 HDL 颗粒的功能分别与 APOA2 和 APOE 的蛋白含量相关。我们的数据表明,不同的颗粒亚群和特定的颗粒相关蛋白提供了关于 HDL 在 CHD 中的作用的新信息。

相似文献

1
Relationships between HDL subpopulation proteome and HDL function in overweight/obese people with and without coronary heart disease.
Atherosclerosis. 2024 Oct;397:118565. doi: 10.1016/j.atherosclerosis.2024.118565. Epub 2024 Aug 13.
2
APOA2 increases cholesterol efflux capacity to plasma HDL by displacing the C-terminus of resident APOA1.
J Lipid Res. 2024 Dec;65(12):100686. doi: 10.1016/j.jlr.2024.100686. Epub 2024 Oct 28.
3
Effects of Recombinant Human Lecithin Cholesterol Acyltransferase on Lipoprotein Metabolism in Humans.
Arterioscler Thromb Vasc Biol. 2024 Jun;44(6):1407-1418. doi: 10.1161/ATVBAHA.123.320387. Epub 2024 May 2.
4
The lipidome and proteome of high-density lipoprotein are altered in menopause.
J Appl Physiol (1985). 2025 Jul 1;139(1):308-324. doi: 10.1152/japplphysiol.00120.2025. Epub 2025 Jun 4.
5
High-Density Lipoprotein Particle Concentration and Size Predict Incident Coronary Artery Disease Events in a Cohort With Type 1 Diabetes.
J Am Heart Assoc. 2024 Jul 16;13(14):e034763. doi: 10.1161/JAHA.123.034763. Epub 2024 Jul 3.
8
High-Density Lipoprotein Lipid and Protein Cargo and Cholesterol Efflux Capacity Before and After Bariatric Surgery.
Arterioscler Thromb Vasc Biol. 2025 Feb;45(2):e48-e62. doi: 10.1161/ATVBAHA.124.321686. Epub 2025 Jan 2.

引用本文的文献

1
HDL proteome: from its characterization to quantitative measurements in particle subspecies and functional associations.
Expert Rev Proteomics. 2025 Jul;22(7):273-286. doi: 10.1080/14789450.2025.2534397. Epub 2025 Jul 22.
2
Effects of fasting on HDL particle function and size distribution.
J Lipid Res. 2025 Jul 5;66(8):100859. doi: 10.1016/j.jlr.2025.100859.
4
High-Density Lipoprotein Particles, Inflammation, and Coronary Heart Disease Risk.
Nutrients. 2025 Mar 28;17(7):1182. doi: 10.3390/nu17071182.
5
Potential causal evidence for an ApoB-independent and HDL-related risk profile associated with coronary artery disease.
J Lipid Res. 2025 Apr;66(4):100778. doi: 10.1016/j.jlr.2025.100778. Epub 2025 Mar 13.
7
Distinct roles of size-defined HDL subpopulations in cardiovascular disease.
Curr Opin Lipidol. 2025 Jun 1;36(3):111-118. doi: 10.1097/MOL.0000000000000959. Epub 2024 Oct 25.

本文引用的文献

3
HDL Isolated by Immunoaffinity, Ultracentrifugation, or Precipitation is Compositionally and Functionally Distinct.
J Lipid Res. 2022 Dec;63(12):100307. doi: 10.1016/j.jlr.2022.100307. Epub 2022 Oct 29.
4
Protein-based HDL subspecies: Rationale and association with cardiovascular disease, diabetes, stroke, and dementia.
Biochim Biophys Acta Mol Cell Biol Lipids. 2022 Sep;1867(9):159182. doi: 10.1016/j.bbalip.2022.159182. Epub 2022 May 20.
5
The role of HDL- and non-HDL-related parameters in cell-cholesterol efflux capacity.
Atherosclerosis. 2022 Mar;345:1-6. doi: 10.1016/j.atherosclerosis.2022.02.012. Epub 2022 Feb 11.
6
Cholesterol Efflux Capacity and Its Association With Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis.
Front Cardiovasc Med. 2021 Dec 13;8:774418. doi: 10.3389/fcvm.2021.774418. eCollection 2021.
7
The HDL Proteome Watch: Compilation of studies leads to new insights on HDL function.
Biochim Biophys Acta Mol Cell Biol Lipids. 2022 Feb;1867(2):159072. doi: 10.1016/j.bbalip.2021.159072. Epub 2021 Nov 18.
8
Reproducible Determination of High-Density Lipoprotein Proteotypes.
J Proteome Res. 2021 Nov 5;20(11):4974-4984. doi: 10.1021/acs.jproteome.1c00429. Epub 2021 Oct 22.
9
Niacin Increases Atherogenic Proteins in High-Density Lipoprotein of Statin-Treated Subjects.
Arterioscler Thromb Vasc Biol. 2021 Aug;41(8):2330-2341. doi: 10.1161/ATVBAHA.121.316278. Epub 2021 Jun 17.
10
HDL in the 21st Century: A Multifunctional Roadmap for Future HDL Research.
Circulation. 2021 Jun 8;143(23):2293-2309. doi: 10.1161/CIRCULATIONAHA.120.044221. Epub 2021 Jun 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验